Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 711Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Casodex

02 2Casodex

PharmaCompass

01

Brand Name : Casodex

Bicalutamide

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Casodex

arrow
The Pharmacy Technology
Not Confirmed

Bicalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 172

2019 Revenue in Millions : 200

Growth (%) : -14

blank

02

Brand Name : Casodex

Bicalutamide

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Casodex

arrow
The Pharmacy Technology
Not Confirmed

Bicalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 143

2020 Revenue in Millions : 172

Growth (%) : -17

blank

03

Brand Name : Casodex

Bicalutamide

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Casodex

arrow
The Pharmacy Technology
Not Confirmed

Bicalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 78

2021 Revenue in Millions : 143

Growth (%) : -45

blank

04

Brand Name : Casodex

Bicalutamide

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Casodex

arrow
The Pharmacy Technology
Not Confirmed

Bicalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 320

2014 Revenue in Millions : 267

Growth (%) : -17%

blank

05

Brand Name : Casodex

Bicalutamide

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Casodex

arrow
The Pharmacy Technology
Not Confirmed

Bicalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 215

2016 Revenue in Millions : 247

Growth (%) : -13

blank

06

Brand Name : Casodex

Bicalutamide

arrow
The Pharmacy Technology
Not Confirmed

07

Brand Name : Casodex

Bicalutamide

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Casodex

arrow
The Pharmacy Technology
Not Confirmed

Bicalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 201

2017 Revenue in Millions : 215

Growth (%) : -7%

blank

08

Brand Name : Casodex

Bicalutamide

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Casodex

arrow
The Pharmacy Technology
Not Confirmed

Bicalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 247

2015 Revenue in Millions : 267

Growth (%) : -7

blank

09

Brand Name : Casodex

Bicalutamide

arrow
The Pharmacy Technology
Not Confirmed

Brand Name : Casodex

arrow
The Pharmacy Technology
Not Confirmed

Bicalutamide

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 200

2018 Revenue in Millions : 201

Growth (%) : 0

blank